CULLINAN THERAPEUTICS, INC. (CGEM) Shareholders’ equity 2020–2022
CULLINAN THERAPEUTICS, INC. (CGEM) shareholders’ equity at each fiscal year-end, per SEC filings.
$535.0MFY2022 · since FY2020: $199.0M → $535.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $535.0M | +25.9% |
| FY2021 | $425.0M | +113.5% |
| FY2020 | $199.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice